- Health Canada DPD: AG-GLICLAZIDE MR (ANGITA PHARMA INC., DIN 02483319) · product monograph (PDF)
- Health Canada DPD: APO-GLICLAZIDE (APOTEX INC, DIN 02245247) · product monograph (PDF)
- Spain CIMA (Spanish): search for “gliclazida” (external search; text not reproduced)
Links only. These regulators' terms do not clearly permit reproducing the documents, so no text is shown here. Check the Philippine package insert in the products table.
Contraindications
- Hypersensitivity to gliclazide, other sulfonylureas or sulfonamides
- Type 1 diabetes; diabetic precoma or coma; diabetic ketoacidosis
- Severe renal or hepatic insufficiency (use insulin)
- Concomitant miconazole
- Breastfeeding
Dosing: Adult
- Type 2 diabetes, modified-release (MR): 30 mg once daily at breakfast to start; increase stepwise (60, 90, 120 mg) at intervals of about 1 month (or after 2 weeks if glucose has not fallen); maximum 120 mg/day
- Type 2 diabetes, immediate-release 80 mg tablets: Start 40–80 mg/day before breakfast; usual maintenance 80–160 mg/day in 2 doses (before breakfast and dinner); maximum 320 mg/day; caution above 160 mg/day, particularly with kidney impairment (IR SmPC)
- Switching: One 80 mg immediate-release tablet is comparable to 30 mg MR; monitor glucose when switching
Dosing: Altered kidney function
Gliclazide is cleared by the liver to inactive metabolites (under 1% leaves unchanged in urine), but hypoglycemia is more likely and can be prolonged in kidney impairment. Irish SmPCs keep the usual regimen with careful monitoring in mild to moderate impairment and contraindicate it in severe renal insufficiency, where insulin is recommended. It has no US FDA label.
Kidney function measure: The SmPCs grade renal impairment as mild, moderate or severe without numeric thresholds; our bands map 'severe' to creatinine clearance (CrCl) below 30 mL/min.
Show full dosing details
- CrCl ≥60 mL/min
- Usual dosing. Modified-release (MR): 30 to 120 mg once daily at breakfast. Immediate-release 80 mg tablets: 40 to 80 mg/day to start, maximum 320 mg/day; doses above 160 mg/day are split before breakfast and dinner (SmPC).
- CrCl 30–59 mL/min
- Mild to moderate impairment: same regimen as normal kidney function with careful glucose monitoring (MR SmPC). Immediate-release: use caution above 160 mg/day and consider limiting the maximum dose as serum creatinine rises (IR SmPC). Start at the lowest dose (MR 30 mg or IR 40–80 mg) and titrate slowly; reduce if hypoglycemia occurs (KDIGO 2022, Figure 6).
- CrCl 15–29 mL/min
- Severe renal insufficiency: contraindicated; insulin is recommended (SmPC). Our mapping of 'severe' to CrCl <30 is a judgment. Off-label use below 30 is a specialist decision: lowest dose, close glucose monitoring.
- CrCl <15 mL/min (not on dialysis)
- Contraindicated (severe renal insufficiency; SmPC).
- Hemodialysis (intermittent)
- Contraindicated (severe renal insufficiency; SmPC). Dialysis does not remove gliclazide because it is highly protein-bound (SmPC 4.9).
- Peritoneal dialysis
- Contraindicated (severe renal insufficiency; SmPC).
- CRRT
- Not appropriate; contraindicated in severe renal insufficiency (SmPC). Use insulin.
- Dialyzable? No: dialysis is of no benefit in overdose because gliclazide is about 95% protein-bound (SmPC 4.9).
- Monitoring Glucose (fasting plasma glucose, glycated hemoglobin [HbA1c], self-monitoring). Hypoglycemia can be prolonged in severe kidney impairment and needs longer observation (SmPC 4.4). Reassess kidney function periodically. G6PD deficiency: sulfonylureas can cause hemolytic anemia; use with caution and consider a non-sulfonylurea alternative (SmPC 4.4).
Children (kidney dosing)
- eGFR ≥60
- Not established in children; kidney dosing not applicable.
- eGFR 30–59
- Not established in children; kidney dosing not applicable.
- eGFR 15–29
- Not established in children; kidney dosing not applicable.
- eGFR <15 (not on dialysis)
- Not established in children; kidney dosing not applicable.
- Hemodialysis (intermittent)
- Not established in children; kidney dosing not applicable.
- Peritoneal dialysis
- Not established in children; kidney dosing not applicable.
- CRRT
- Not established in children; kidney dosing not applicable.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
Source: HPRA (Ireland) product information (March 2025). This generic has no US FDA label.
Dosing: Pediatric
- Approved ages
- Not established in children and adolescents (SmPC).
- Usual dose
- Not established.
Not for pediatric use.
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedDosage forms
Philippines
- Modified-release tablet: 30 mg, 60 mg, 80 mg
- Tablet: 80 mg
- Prolonged-release tablet: 30 mg, 60 mg
- Monitored-release tablet: 80 mg
- Sustained-release tablet: 30 mg, 60 mg
- Modified tablet: 60 mg
Registered products in the Philippines
164 products registered with the Food and Drug Administration (FDA) Philippines list Gliclazide as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: GIiclazide (1 product, possible match).
All registered products164
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Aglic MRGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma LimitedIndia | Ellebasy Medicale TradingImporter: Pharmakon Biotec Inc. | DRP-5769-01 | Jun 13, 2029 | |
AglizaGliclazide | 80 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Healer's Lab (Unit II)India | Teramedix Pharma Trading Inc. | DRP-16519 | Apr 8, 2030 | |
Azukon MrGliclazide | 30MG Prolonged-Release TabletAlu/PVC Blister Pack x 10's (Box of 100's). | RxVAT-exempt | Torrent Pharmaceuticals, Ltd.India | Torrent Pharma Philippines, Inc. | DRP-3777 | May 30, 2028 | |
Azukon MR 30Gliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Torrent Pharma Philippines, Inc.Importer: Ambica International Corporation | DRP-8993-10 | Jun 29, 2030 | |
Azukon MR 60Gliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Torrent Pharma Philippines, Inc.Importer: Ambica International Corporation | DRP-8994-17 | Aug 14, 2030 | |
Clazicare 30Gliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Medcare PharmaceuticalsImporter: Ambica International Corporation | DRP-8993-09 | Jul 29, 2030 | |
Clazicare 60Gliclazide | 60 mg Modified Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | Medcare PharmaceuticalsImporter: Ambica International Corporation | DRP-15242-06 | May 30, 2029 | |
CLAZINEXGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Ltd.India | D'Conner PharmaImporter: Pharmakon Biotec Inc. | DRP-5769-14 | Jun 13, 2029 | |
ClizidGliclazide | 80 mg TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | Trader: Sandoz Philippines Corporation | DRP-1256 | May 7, 2029 | |
DiaclazGliclazide | 80 mg TabletAlu/ PVC Blister Pack x 10's (Box of 30's & 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-12894-03 | Jan 25, 2027 | |
Diaglez-60Gliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Zeldix Pharma Inc.Importer: Pharmakon Biotec Inc. | DRP-15107-03 | Dec 20, 2028 | |
Diaglez-80Gliclazide | 80 mg TabletAlu/PVC Blister Pack x 10’s (Box of 30’s & 100’s) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Zeldix Pharma Inc.Importer: Pharmakon Biotec Inc. | DRP-12894-02 | Jan 25, 2027 | |
Diagluzide MrGliclazide | 60 mg Sustained Released TabletPolycellonium Strip Pack x 10’s (Box of 30's) | RxVAT-exempt | PT Dexa MedicalIndonesia | Glorious Dexa Mandaya, Inc. | DRP-14196 | Jul 18, 2028 | |
DiakonGliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec, Inc. | DR-XY47672 | Jan 25, 2027 | |
DiakonGliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's & 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec Inc. | DRP-12894 | Jan 25, 2032 | |
Diakon MRGliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec, Inc. | DR-XY48947 | Dec 20, 2028 | |
Diakon MRGliclazide | 60 mg Modified-Release TabletAlu/ PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec Inc. | DRP-15107 | Dec 20, 2028 | |
DiameedGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | MeedPharma Medical Supplies & Equipment DistributorTrader: D.B. Manix International, Inc. | DR-XY43808 | Oct 17, 2029 | |
DiamicronGliclazide | 80 mg TabletAlu/ PVC Blister Pack x 20's (Box of 100's); Alu/ PVC Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Les Laboratoires Servier IndustrieFrance | Zuellig Pharma CorporationImporter: Servier Philippines, Inc. | DR-X626 | Mar 20, 2028 | |
Diamicron MRGliclazide | 60 mg Modified-Release TabletAlu-PVC blister pack x 15's (Box of 60's) | RxVAT-exempt | Les Laboratoires Servier lndustrieFrance | Zuellig Pharma CorporationImporter: Servier Philippines, Inc. | DR-XY38522 | Sep 21, 2030 | |
Diamilem-30Gliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-8993-08 | Jul 29, 2030 | |
DiamirGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Ltd.India | Pharmakon Biotec Inc. | DRP-5769 | Jun 13, 2029 | |
DiamopsivGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Ltd.India | Vispomed CorporationImporter: Pharmakon Biotec Inc. | DRP-5769-08 | Jun 13, 2029 | |
DiasarGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-5769-06 | Jun 13, 2029 | |
DiaxidGliclazide | 80 mg TabletAlu/Alu Blister Pack of 10's (Box of 100's) | RxVAT-exempt | Healer's Lab (Unit II)India | Pharmakon Biotec Inc. | DRP-13515 | Mar 3, 2028 | |
GalzidGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma LimitedIndia | ECE Pharmaceuticals, Inc.Importer: Pharmakon Biotec Inc. | DRP-5769-03 | Jun 13, 2029 | |
GiclazGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Ltd.India | Gijun Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-5769-09 | Jun 13, 2029 | |
GlazideGliclazide | 80 mg TabletAlu/PVC-PVDC Blister Pack x 10's Box of 60's | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | TGP PHARMA INC.Trader: Sandoz Philippines Corporation | DRP-1256-01 | May 7, 2029 | |
GlazziGliclazide | 60 mg Modified Release TabletAlu/PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | 4Care Lifescience Pvt. Ltd.India | AGlobal Care, Inc.Importer: Aglobal Care, Inc. | DRP-15952 | Oct 3, 2029 | |
GlibeyGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-5769-04 | Jun 13, 2029 | |
GlicamedGliclazide | 80 mg TabletAlu/ Clear PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Medico Remedies LimitedIndia | Medethix, Inc.Importer: MedEthix, Inc. | DRP-6485 | Dec 21, 2031 | |
Glicanov 60Gliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | S Kant Healthcare Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-16157-01 | Dec 3, 2029 | |
GlicarexGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC blister pack x 10's Box of 30's | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DR-XY46231 | Jan 26, 2028 | |
GlicarexGliclazide | 80 mg Modified-Release TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DR-XY44849 | Oct 1, 2030 | |
GlicazenGliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-12894-05 | Jan 25, 2027 | |
GlicgardGliclazide | 80 mg Monitored-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-7798 | Oct 1, 2030 | |
Glicla-NatrapharmGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 60's); Alu/Claear PVDC Blister Pack x 15's (Box of 15's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Natrapharm, Inc. | DR-XY38504 | Sep 15, 2030 | |
GliclaformGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-8994-04 | Apr 5, 2031 | |
GliclaphilGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Phil Asia Pharma Inc.Importer: Ambica International Corporation | DRP-8994-08 | Aug 14, 2030 | |
GliclapremGliclazide | 60 mg Modified Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-15242-04 | May 30, 2029 | |
GliclaproGliclazide | 80 mg Monitored-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Transcend Phils., Inc. | DRP-7630 | Oct 1, 2030 | |
GliclastanGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's); Alu/Clear PVDC Blister Pack x 10's (Box of 1's Physician Sample) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Gold Life Distribution Phils. Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-6997-02 | Feb 28, 2029 | |
Gliclasy 60Gliclazide | 60 mg Modified-Release TabletAlu/ PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Ellebasy Medicale Group Inc.Importer: Pharmakon Biotec Inc. | DRP-15107-02 | Dec 20, 2028 | |
Gliclasy 80Gliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's & 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Ellebasy Medicale Group Inc.Importer: Pharmakon Biotec Inc. | DRP-12894-04 | Jan 25, 2027 | |
GliclaxGliclazide | 60 mg Modified Release TabletAlu / Clear PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | Diafarm Inc.Importer: Ambica International Corporation | DRP-15242-02 | May 30, 2029 | |
Gliclazet 60Gliclazide | 60 mg Modified Release TabletAlu/PVC Blister Pack of 10’s (Box of 100’s) | RxVAT-exempt | Sai Parenterals Ltd.India | Eliset Pharmaceuticals, Inc.Importer: Nelpa Lifesciences, Inc. | DRP-10683-03 | Feb 14, 2030 | |
GliclazinGliclazide | 60 mg Modified Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-15242-03 | May 30, 2029 | |
GliclydeGliclazide | 60 mg Modified Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | Ambica International Corporation | DRP-15242 | May 30, 2029 | |
GlicronGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Rilem Pharma Corp.Importer: Ambica International Corporation | DRP-8993-11 | Jul 29, 2030 | |
Glifred MRGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc. | DRP-13892 | May 12, 2028 | |
Glifred MRGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-13893 | May 12, 2028 | |
Gliget MRGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10’s (Box of 30’s) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Getz Pharma (Phils.), Inc.Importer: Ambica International Corporation | DRP-8994-09 | Aug 14, 2030 | |
Glik-SGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Starpharm, Inc.Importer: Ambica International Corporation | DRP-8994-13 | Aug 14, 2030 | |
GliklantGliclazide | 60 mg Modified Release TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | Aglobal Care, Inc. | DRP-15953 | Oct 3, 2029 | |
GlimcoseGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's and 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-8993-02 | Jul 29, 2030 | |
GlimcoseGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's and 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-8994-05 | Aug 14, 2030 | |
GlimyxGliclazide | 60 mg Modified Release TabletAlu-PVC Blister Foil pack x 10's (Box of 30's) | RxVAT-exempt | The ACME Laboratories LimitedBangladesh | Euro Generics International Phils., Inc. | DRP-16481 | Apr 18, 2029 | |
GlitabGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's Box of 100's | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Littman Drug Corporation | DR-XY43702 | Sep 3, 2029 | |
GlitrisGliclazide | 30mg Modified Release TabletsAlu-PVC Blister Pack x 10's | RxVAT-exempt | Baroque Pharmaceuticals Private LimitedIndia | AMB HK Enterprises Inc. | DRP-18030 | Apr 28, 2032 | |
GlitrisGliclazide | 60 mg Modified-Release TabletAlu-PVC Blister Pack x 4's (Box of 4's) | RxVAT-exempt | Baroque Pharmaceuticals Private LimitedIndia | AMB HK Enterprises Inc. | DRP-18029 | Apr 28, 2032 | |
GliveriaGliclazide | 30 mg Modified Release TabletAlu / PVC / PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Private LimitedIndia | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-18199-01 | May 26, 2032 | |
GliXaGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10’s (Box of 60’s) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Innogen Pharmaceuticals, Inc.Importer: Ambica International Corporation | DRP-8994-10 | Aug 14, 2030 | |
Glizanov MRGliclazide | 60 mg Modified Release TabletAlu/PVC/PVDC Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Ratnatris Pharmaceuticals Private LimitedIndia | Medinova Pharmaceutical Inc. | DRP-18198 | May 26, 2032 | |
Glizen 30Gliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Ltd.India | Hale Medipoint Corp.Importer: Pharmakon Biotec Inc. | DRP-5769-11 | Jun 13, 2029 | |
Glizen 60Gliclazide | 60 mg Modified-Release TabletAlu/ PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Hale Medipoint Corp.Importer: Pharmakon Biotec Inc. | DRP-15107-1 | Dec 20, 2028 | |
Glizen 80Gliclazide | 80 mg TabletAlu / PVC Blister Pack x 10's (Box of 30's & 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Hale Medipoint Corp.Importer: Pharmakon Biotec Inc. | DRP-12894-06 | Jan 25, 2027 | |
GlubitorGliclazide | 80 mg TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | Unilab, Inc.Trader: SANDOZ PHILIPPINES CORPORATION | DRP-1256-03 | May 7, 2029 | |
Glubitor-ODGliclazide | 30 mg Modified Release TabletBlister Pack x 10's (Box of 60's) | RxVAT-exempt | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-10040 | Jun 6, 2027 | |
Glubitor-OdGliclazide | 30 mg Sustained-Release TabletAlu/PVC/PVDC Blister Pack x 10' s (Box of 100' s) | RxVAT-exempt | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-14154 | Jun 30, 2028 | |
Glubitor-ODGliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Centaur Pharmaceuticals Private Limited.India | UNILAB, Inc., | DRP-15998 | Oct 10, 2029 | |
Glubitor-ODGliclazide | 60 mg Prolonged-Release TabletAlu/Alu Blister Pack x 15's (Box of 60's) | RxVAT-exempt | Krka, D.D., Novo MestoSlovenia | UNILAB, Inc.Importer: Ambicare Pharmaceuticals Inc. | DRP-8992-01 | Mar 2, 2031 | |
Gluclazide SRGliclazide | 30 mg Prolonged-Release TabletAlu/Alu Blister Pack x 15's (Box of 60's) | RxVAT-exempt | Krka, D.D., Novo MestoSlovenia | Ambicare Pharmaceuticals Inc. | DRP-16291 | Jan 28, 2030 | |
Gluclazide SRGliclazide | 60 mg Prolonged -Release TabletAlu/Alu Blister Pack x 15's (Box of 60's) | RxVAT-exempt | Krka, D.D., Novo MestoSlovenia | Ritemed Phils., Inc.Importer: Ambicare Pharmaceuticals Inc. | DRP-8992 | Jul 29, 2030 | |
Gluclazz 30Gliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-8993-01 | Jul 29, 2030 | |
Gluclazz 60Gliclazide | 60 mg Modified Release TabletAlu-PVC Blister Foil pack x 10's (Box of 30's) | RxVAT-exempt | The ACME Laboratories LimitedBangladesh | Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc. | DRP-16481-02 | Apr 18, 2029 | |
Gluclazz 60Gliclazide | 60 mg Modified Release TabletAlu-PVC Blister Foil pack x 10's (Box of 30's) | RxVAT-exempt | The ACME Laboratories LimitedBangladesh | Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc. | DRP-16481-03 | Apr 18, 2029 | |
Gluclazz MRGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Bell-Kenz Pharma Inc.Importer: Ambica International Corporation | DRP-8994-03 | Aug 14, 2030 | |
Gluconex MRGliclazide | 30 mg Modified-Release TabletAlu/Alu Blister Pack x 10's (Box of 30's and 60's) | RxVAT-exempt | Lek Pharmaceuticals d.d.Slovenia | The Cathay YSS Distributors Co., Inc.Importer: Sandoz Philippines Corporation | DRP-4138-02 | Dec 13, 2027 | |
Gluconex MRGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Ltd.India | The Cathay YSS Distributors Co., Inc.Importer: Pharmakon Biotec Inc. | DRP-5769-07 | Jun 13, 2029 | |
Gluconex ODGliclazide | 60 mg Modified Release TabletAlu/PVC/PVDC Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Inventia Healthcare LimitedIndia | The Cathay YSS Distributors Co., Inc.Trader: N/A | DRP-15951 | Oct 3, 2029 | |
Gluconex ODGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | The Cathay YSS Distributors Co., Inc.Importer: Ambica International Corporation | DRP-8994-01 | Aug 14, 2030 | |
GluconilGliclazide | 80 mg TabletPVC-Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Biolab Co., Ltd.Thailand | The Cathay YSS Distributors Co., Inc. | DR-XY24279 | Mar 15, 2028 | |
Glucor MR 60Gliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. LtdIndia | Despina Pharma Inc. | DRP-14439 | Oct 17, 2028 | |
GlucronGliclazide | 80 mg Modified-Release TabletClear PVDC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Vitalink Health Products, Inc. | DR-XY43703 | Sep 3, 2029 | |
Glycazin 80Gliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | S Kant Healthcare Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-17476-01 | Jan 8, 2031 | |
Glycenil Mr 60Gliclazide | 60 mg Modified Release TabletAlu/Alu Blister pack x 10's (Box of 100' s) | RxVAT-exempt | Unison Laboratories Co., Ltd.Thailand | Justright Healthcare Inc. | DRP-14143 | Jun 30, 2028 | |
Glycinorm-80Gliclazide | 80 mg TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Ipca Laboratories Ltd.India | Blue Global (FZE) | DRP-6571 | Jul 30, 2029 | |
Glycinorm-MR 30Gliclazide | 30mg Modified-Release TabletAlu/Alu Blister Pack x 10's Box of 30's and 60's | RxVAT-exempt | IPCA Laboratories Ltd.India | Blue Global (FZE) | DRP-5476 | May 15, 2027 | |
Glycinorm-MR 60Gliclazide | 60 mg Prolonged-Release TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | IPCA Laboratories LimitedIndia | Blue Global (FZE) | DRP-14700 | Nov 30, 2028 | |
GlycocGliclazide | 80mg TabletAlu-PVC/PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-14240 | Aug 2, 2028 | |
Glynoprex MRGliclazide | 60 mg Modified Release TabletAlu-PVC Blister Foil Pack x 10'ss (Box of 30's) | RxVAT-exempt | The ACME Laboratories LimitedBangladesh | Euro Generics International Phils., Inc. | DR-XY49056 | Apr 18, 2029 | |
GlysaVEGliclazide | 60 mg Modified Release TabletAlu / PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | Savelink Pharma and Trading Co.Importer: AGlobal Care Inc. | DRP-15953-01 | Oct 3, 2029 | |
Glythix MRGliclazide | 30 mg Modified Release TabletAlu/Clear Transparent PVC Blister Pack (Box of 100's) | RxVAT-exempt | Pharose Remedies LimitedIndia | MedEthix, Inc. | DRP-14579 | Oct 18, 2028 | |
Glythix MRGliclazide | 60 mg Modified Release TabletAlu/Clear Transparent PVC Blister Pack (Box of 30's) | RxVAT-exempt | Pharose Remedies Limited.India | MedEthix, Inc. | DRP-14581 | Oct 18, 2028 | |
Goclaz 60Gliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100’s) | RxVAT-exempt | Fredun Pharmaceuticals LimitedIndia | Applied Pharmaceutical Distribution IncImporter: AMB HK Enterprises Inc. | DRP-13893-01 | May 12, 2028 | |
Goclaz 80Gliclazide | 80 mg TabletAlu-PVC/PVDC Blister Pack x 10’s (Box of 30’s and 100’s) | RxVAT-exempt | Fredun Pharmaceuticals LimitedIndia | Applied Pharmaceutical Distribution IncImporter: AMB HK Enterprises Inc. | DRP-14240-01 | Aug 2, 2028 | |
Grimgor-SMAGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10’s (Box of 60’s) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Santemed Medical Equipment and Supplies TradingImporter: Ambica International Corporation | DRP-8993-07 | Jul 29, 2030 | |
KodizideGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Kodi Biosciences IncImporter: Ambica International Corporation | DRP-8994-14 | Apr 5, 2031 | |
LifeclazGliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Innovative HealthcareIndia | Biophil Medical Equipment and Supplies Trading | DRP-18805 | Sep 22, 2031 | |
LifeclazGliclazide | 80 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of30's, and 100's) | RxVAT-exempt | Azine Healthcare Pvt. Ltd.India | Checked and Signed by CDRR21 for CDRR40 then forwarded to LRDImporter: Biophil Medical Equipment and Supplies Trading | DRP-18243 | Jun 3, 2031 | |
Mediclazide 80Gliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | S Kant Healthcare Ltd.India | Medinova Pharmaceutical Inc. | DRP-17476 | Jan 8, 2031 | |
Melanov MR 30Gliclazide | 30 mg Modified Release TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Micro Labs limitedIndia | Brown & Burk Philippines, Inc. | DRP-5545 | Sep 26, 2029 | |
Melanov MR 60Gliclazide | 60 mg Modified TabletAlu/Clear PVC Blister Pack x 10's (B0x of 30's and 100's) | RxVAT-exempt | Micro Labs LimitedIndia | Brown & Burk Philippines Inc. | DRP-7997 | Sep 16, 2029 | |
Neoclazz MRGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10’s (Box of 60’s) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-8993-03 | Jul 29, 2030 | |
Neoclazz MRGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-8994-02 | Aug 14, 2030 | |
NoneGliclazide | 30 mg Modified Release TabletAlu/Clear PVC Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Sapphire Lifesciences Pvt. Ltd.India | Ambitech Biopharmaceuticals Inc.Importer: Nelpa Lifesciences, Inc. | DRP-11488-01 | Mar 17, 2027 | |
NoneGliclazide | 30 mg Modified Release TabletAlu/ PVDC Blister pack x 10's Box of 100's | RxVAT-exempt | Ranbaxy (Malaysia) SDN. BHD.Malaysia | Ritemed Phils., Inc.Importer: Sun Pharma Philippines, Inc. | DRP-3152-01 | Aug 4, 2029 | |
NoneGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Actimed, Inc.Importer: Ambica International Corporation | DRP-8993-05 | Apr 5, 2031 | |
NoneGliclazide | 30 mg Modified-Release TabletAlu-Clear PVDC Blister Pack x 10's (Box of 30's) - DOH Complete Treatment Pack | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DR-XY43689 (For DOH Only) | Aug 28, 2031 | |
NoneGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | TGP Pharma Inc.Trader: Foramen Products Corporation | DR-XY43756 | Sep 26, 2029 | |
NoneGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-10389 | May 25, 2030 | |
NoneGliclazide | 30 mg Modified-Release TabletAlu/Alu Blister Pack x 10's Box of 30's and 60's | RxVAT-exempt | Lek Pharmaceuticals d.d.Slovenia | Sandoz Philippines Corporation | DRP-4138 | Dec 13, 2027 | |
NoneGliclazide | 30 mg Modified-Release TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lek Pharmaceuticals d.d.Slovenia | TGP Pharma Inc.Importer: Sandoz Philippines Corporation | DRP-4138-03 | Dec 13, 2027 | |
NoneGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma LimitedIndia | Zydus Healthcare Philippines Inc.Importer: Pharmakon Biotec Inc. | DRP-5769-10 | Jun 13, 2029 | |
NoneGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's); Alu/Clear PVDC Blister Pack x 10's (Box of 1's Physician Sample) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-6997 | Feb 28, 2029 | |
NoneGliclazide | 30 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's Box of 30's | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Watsons Personal Care Stores (Philippines), Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-6997-01 | Feb 28, 2029 | |
NoneGliclazide | 60 mg Modified Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100’s) | RxVAT-exempt | S Kant Healthcare Ltd.India | PharmaVital Corp.Importer: Ambica International Corporation | DRP-15242-07 | May 30, 2029 | |
NoneGliclazide | 60 mg Modified Release TabletAlu-PVC Blister Foil pack x 10's (Box of 30's) | RxVAT-exempt | The ACME Laboratories LimitedBangladesh | Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc. | DRP-16481-01 | Apr 18, 2029 | |
NoneGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | TGP Pharma Inc.Importer: Ambica International Corporation | DRP-8994-06 | Aug 14, 2030 | |
NoneGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10’s (Box of 60's and 100’s) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Watsons Personal Care Stores (Philippines), Inc.Importer: Ambica International Corporation | DRP-8994-07 | Aug 14, 2030 | |
NoneGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Actimed, Inc.Importer: Ambica International Corporation | DRP-8994-12 | Aug 14, 2030 | |
NoneGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-8994-15 | Aug 14, 2030 | |
NoneGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | South Star DrugImporter: Ambica International Corporation | DRP-8994-16 | Aug 14, 2030 | |
NoneGliclazide | 60 mg Modified Release TabletAlu / Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-8994-18 | Aug 14, 2030 | |
NoneGliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India 174101 | Reta DrugImporter: Pharmakon Biotec Inc. | DRP-15107-05 | Aug 4, 2029 | |
NoneGliclazide | 80 mg Modified Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Vitalink Health Products, Inc. | DRP-8572 | Jun 16, 2030 | |
NoneGliclazide | 80 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: DB Manix International, Inc. | DR-XY43681 | Aug 28, 2029 | |
NoneGliclazide | 80 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Euro-Health Care Exponents, Inc. | DR-XY43682 | Aug 28, 2029 | |
NoneGliclazide | 80 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Dyna Drug Corporation | DR-XY43785 | Oct 10, 2029 | |
NoneGliclazide | 80 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | TGP Pharma Inc.Trader: Foramen Products Corporation | DR-XY43810 | Oct 27, 2029 | |
NoneGliclazide | 80 mg Modified-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Watsons Personal Care Stores (Philippines), Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-7798-01 | Aug 6, 2031 | |
NoneGliclazide | 80 mg Monitored-Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Actimed, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-11751 | Oct 1, 2030 | |
NoneGliclazide | 80 mg TabletAlu/PVC Blister pack x 10's (Box of 100's) | RxVAT-exempt | Sai Parenterals Ltd.TSIIC Industrial Park Hyderabad-Warangal Highway Bhongir Telangana 508116 India | PharmaVital Corp.Importer: Nelpa Lifesciences, Inc. | DRP-10560-02 | Mar 26, 2031 | |
NoneGliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Zydus Healthcare Philippines Inc.Importer: Pharmakon Biotec Inc. | DRP-12894-01 | Jan 25, 2027 | |
NoneGliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India 174101 | Reta DrugImporter: Pharmakon Biotec Inc. | DRP-12894-07 | Jan 25, 2027 | |
NoneGliclazide | 80 mg TabletAlu/PVC-PVDC Blister Pack x 10's Box of 30's and 100's | RxVAT-exempt | Ipca Laboratories LimitedIndia | TGP Pharma Inc.Importer: Blue Global (FZE) | DRP-6571-04 | Jul 30, 2029 | |
NoneGliclazide | 80 mg TabletAlu/Alu Blister Pack x 10's (Box of 100 's) | RxVAT-exempt | Hovid BerhadMalaysia | Actimed, Inc.Importer: Hovid, Inc. | DRP-6726-01 | Nov 29, 2028 | |
PillclazGliclazide | 60 mg Modified Release TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-15242-05 | May 30, 2029 | |
Proglitab MR 30Gliclazide | 30 mg Modified-Release TabletAlu/ Alu Blister Pack 6 X 10's (Box of 60's) | RxVAT-exempt | Inventia Healthcare LimitedIndia | Healol Pharma Corporation | DRP-15473 | Jul 12, 2029 | |
Proglitab MR 60Gliclazide | 60mg Modified-Release TabletAlu-PVC/PVDC Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Inventia Healthcare LimitedIndia | Healol Pharma Corporation. | DRP-14930 | Feb 27, 2029 | |
RetamicronGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10’s (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Reta DrugImporter: Ambica International Corporation | DRP-8993-06 | Jun 9, 2031 | |
RetamicronGliclazide | 60 mg Modified Release TabletAlu/Clear PVDC Blister Pack x 10’s (Box of 100's) | RxVAT-exempt | S Kant Healthcare LimitedIndia | Reta DrugImporter: Ambica International Corporation | DRP-15242-01 | May 30, 2029 | |
Saphclazide 30Gliclazide | 30 mg Modified Release TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sapphire Lifesciences Pvt. Ltd.India | Nelpa Lifesciences, Inc. | DRP-11488 | Mar 17, 2027 | |
Saphclazide-60Gliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sai Parenterals Ltd.India | Nelpa Lifesciences, Inc. | DRP-10683 | Feb 14, 2030 | |
Saphclazide-80Gliclazide | 80 mg TabletAlu/PVC Blister pack x 10's (Box of 100's) | RxVAT-exempt | Sai Parenterals Ltd.India | Nelpa Lifesciences, Inc. | DRP-10560 | Mar 26, 2031 | |
Saphclazide-G60Gliclazide | 60 mg Modified Release TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Global Pharma Healthcare Private LimitedIndia | Nelpa Lifesciences Inc. | DRP-17396 | Dec 10, 2030 | |
Saphlurea-GE30Gliclazide | 30 mg Modified Release TabletAlu/PVC Blister Pack x 10’s (Box of 30’s, 60’s, 90’s and 100’s) | RxVAT-exempt | Genom Biotech Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: N/A | DRP-17668 | Feb 13, 2031 | |
Saphlurea-GE80Gliclazide | 80 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's, 60's, 90's and 100's) | RxVAT-exempt | Genom Biotech Pvt. Ltd.India | Nelpa Lifesciences, Inc. | DRP-17560 | Jan 23, 2031 | |
UnbrandedGliclazide | 30 mg Modified Release TabletAlu/ PVDC Blister Pack x 10's Box of 100's | RxVAT-exempt | Ranbaxy (Malaysia) Sdn. Bhd.Malaysia | Importer: Sun Pharma Philippines, Inc. | DRP-3152 | Aug 4, 2029 | |
UnbrandedGliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10's Box of 30's and 100's | RxVAT-exempt | S KANT HEALTHCARE LTD.India | Qualifirst Health Inc.Importer: Medinova Pharmaceutical Inc. | DRP-16157-02 | Dec 3, 2029 | |
UnbrandedGliclazide | 80 mg TabletAlu/PVC-PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Ipca Laboratories LimitedIndia | International Pharmaceuticals, Inc.Importer: Blue Global (FZE) | DRP-6571-02 | Jul 30, 2029 | |
Xbloc-30 MRGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's and 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Preventia Healthcare Inc.Importer: Ambica International Corporation | DRP-8993-04 | Jul 29, 2030 | |
XBloc-30 MRGliclazide | 30 mg Modified-Release TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | IPCA Laboratories Ltd.India | Preventia Healthcare Inc.Importer: Blue Global (FZE) | DRP-5476-03 | May 15, 2027 | |
Xbloc-60 MRGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's and 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Preventia Healthcare Inc.Importer: Ambica International Corporation | DRP-8994-11 | Aug 14, 2030 | |
ZebetGliclazide | 80 mg TabletAlu/AIu BIister Pack x 10's (Box of 100's) | RxVAT-exempt | Hovid BerhadMalaysia | Hovid Inc. | DRP-6726 | Nov 29, 2028 | |
Zeldin-MRGliclazide | 30 mg Modified-Release TabletPVC / Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma LimitedIndia | Medchoice Endocrine Group, Inc.Importer: Pharmakon Biotec Inc. | DRP-5769-13 | Jun 13, 2029 | |
Zeltin-MRGliclazide | 30 mg Modified-Release TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Bal Pharma Limited (Unit-I)India | Medchoice Endocrine Group, Inc.Importer: Pharmakon Biotec Inc. | DRP-5769-12 | Jun 13, 2029 | |
Zeltine-MRGliclazide | 30 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 60's and Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Medchoice Endocrine Group, Inc.Importer: Ambica International Corporation | DRP-8993 | Jul 29, 2030 | |
Zeltine-MRGliclazide | 60 mg Modified Release TabletAlu/Alu Blister Pack x 10's (Box of 30's , 60's and 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Medchoice Endocrine Group, Inc.Importer: Ambica International Corporation | DRP-8994 | Aug 14, 2030 | |
Zeltine-MRGliclazide | 60 mg Modified-Release TabletAlu/ PVC Blister Pack x 10's (Box of 60's and Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Medchoice Endocrine Group, Inc.Importer: Pharmakon Biotec Inc. | DRP-15107-04 | Dec 20, 2028 | |
ZidinexGliclazide | 60 mg Modified-Release TabletAlu/PVC Blister Pack x 10's (Box of 60's and 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | D'Conner PharmaImporter: Pharmakon Biotec Inc. | DRP-15107-06 | Dec 20, 2028 | |
(no brand name)Gliclazide | 30 mg Modified Release TabletAlu/Clear Transparent PVC Blister Pack (Box of 100's) | RxVAT-exempt | Pharose Remedies LimitedIndia | MedEthix, Inc. | DRP-14580 | Oct 18, 2028 | |
(no brand name)Gliclazide | 30 mg Sustained-Release TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | United International Pharma Co. Ltd.Vietnam | RiteMed Phils., Inc. | DRP-10441 | Dec 10, 2026 | |
(no brand name)Gliclazide | 60 mg Modified Release TabletAlu/Clear Transparent PVC Blister Pack x (Box of 30's) | RxVAT-exempt | Pharose Remedies LimitedIndia | MedEthix, Inc. | DRP-14582 | Oct 18, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Miconazole (systemic, oral gel) | Avoid | Strong rise in hypoglycemia risk, possibly coma. | Contraindicated. |
| Phenylbutazone, alcohol, danazol | Adjust or monitor | Phenylbutazone and alcohol increase hypoglycemia; danazol raises glucose. | Not recommended; choose alternatives or monitor glucose and adjust the dose. |
| Fluoroquinolones | Adjust or monitor | Dysglycemia (hypo- or hyperglycemia), especially in older adults. | Monitor glucose closely. |
| Insulin, metformin, beta-blockers, fluconazole, NSAIDs, clarithromycin, MAO inhibitors | Adjust or monitor | May potentiate hypoglycemia. | Monitor glucose; lower the gliclazide dose if needed. |
| Warfarin and other oral anticoagulants | Adjust or monitor | Sulfonylureas may increase the anticoagulant effect. | Monitor the international normalized ratio (INR); adjust the anticoagulant. |
| Glucocorticoids, high-dose chlorpromazine, St John's wort | Minor | Raise glucose or lower gliclazide exposure. | Monitor glucose and adjust. |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewedAdverse reactions
Common
- Hypoglycemia (especially with irregular or skipped meals)
- Gastrointestinal upset: abdominal pain, nausea, vomiting, dyspepsia, diarrhea, constipation (uncommon)
Serious
- Severe or prolonged hypoglycemia needing hospital care
- Blood disorders (anemia, leukopenia, thrombocytopenia, granulocytopenia; agranulocytosis and hemolytic anemia as class effects)
- Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS)
- Hepatitis, cholestatic jaundice
Monitoring parameters
- Glucose (fasting plasma glucose, glycated hemoglobin [HbA1c], self-monitoring). Hypoglycemia can be prolonged in severe kidney impairment and needs longer observation (SmPC 4.4). Reassess kidney function periodically. G6PD deficiency: sulfonylureas can cause hemolytic anemia; use with caution and consider a non-sulfonylurea alternative (SmPC 4.4). Kidney
- Fasting plasma glucose and HbA1c
- Hypoglycemia symptoms, especially in older adults, poor intake and kidney impairment
- Kidney and liver function periodically
- G6PD deficiency: sulfonylureas can cause hemolytic anemia; use with caution and consider a non-sulfonylurea alternative (SmPC 4.4)
Pharmacokinetics
Key PK parameters
| Bioavailability | Completely absorbed; food does not affect absorption (MR SmPC) |
|---|---|
| Time to peak | MR: plasma levels rise over 6 hours and plateau from 6 to 12 hours |
| Half-life | MR: 12 to 20 hours; immediate-release: mean 10 hours |
| Half-life in kidney failure (ESKD) kidney | Immediate-release SmPC: prolonged slightly, not significantly, in renal insufficiency; not quantified |
| Volume of distribution | About 30 L |
| Protein binding | About 95% |
| Metabolism (CYP, transporters) | Extensive hepatic metabolism (enzymes not named in SmPC) |
| Active metabolites | None detected in plasma |
| Renal excretion kidney | Metabolites mainly in urine; under 1% unchanged |
| Dialyzability kidney | No (highly protein-bound; SmPC 4.9) |
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Gliclazide 30 mg MR Tablet | ₱2.00–₱3.50Reference ₱2.60 | per tablet | DPRI procurement range |
| Gliclazide 60 mg MR Tablet | ₱7.07–₱20.00Reference ₱9.28 | per tablet | DPRI procurement range |
| Gliclazide 80 mg Tablet | ₱2.21–₱7.30Reference ₱3.12 | per tablet | DPRI procurement range |
| 30 mg modified release tablet | ₱6.75 | per tablet | PhilHealth GAMOT fixed fee |
| 60 mg modified release tablet | ₱27.00 | per tablet | PhilHealth GAMOT fixed fee |
| 80 mg tablet | ₱2.50 | per tablet | PhilHealth GAMOT fixed fee |
PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf, as of October 13, 2026
Formulary and coverage
| Philippine National Formulary | Listed as Gliclazide |
| PNF listing | Oral: 30 mg and 60 mg MR tablet |
| PNF listing | Oral: 80 mg tablet |
| PhilHealth GAMOT | Yes (listed since July 28, 2025) |
| PhilHealth YAKAP (formerly Konsulta) | Yes |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Health Products Regulatory Authority (Ireland). Diacronal MR 60 mg modified-release tablets SmPC (PA1347/024/001) [HPRA (Ireland) product information, March 2025; no US FDA label]. https://assets.hpra.ie/products/Human/26648/Licence_PA1347-024-001_11112025105324.pdf
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- KRKA, d.d. (2025). Diacronal MR 60 mg modified-release tablets (gliclazide) [Summary of product characteristics, licence PA1347/024/001; text revised March 2025]. Health Products Regulatory Authority (Ireland). https://assets.hpra.ie/products/Human/26648/Licence_PA1347-024-001_11112025105324.pdf
- L. Molteni & C. dei F.lli Alitti. (2020). Diabrezide 80 mg tablets (gliclazide) [Summary of product characteristics, licence PA0925/001/001; text revised October 2020]. Health Products Regulatory Authority (Ireland). https://assets.hpra.ie/products/Human/22991/Licence_PA0925-001-001_27102020190156.pdf
- Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. (2022). KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney International, 102(5S), S1–S127. https://doi.org/10.1016/j.kint.2022.06.008
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .
